Teriparatide
Treatment for Osteoporosis
Typical Dosage: 20 mcg subcutaneous injection once daily
Effectiveness
70%
Safety Score
55%
Clinical Trials
131
Participants
5.5K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
55
DangerousModerateSafe
Treatment Details
Dosage Range
20 mcg subcutaneous injection once daily
Time to Effect
6-12 months
Treatment Duration
Up to 2 years lifetime maximum
Evidence Quality
HIGHNumber Needed to Treat (NNT)
11(Treat 11 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
500(Treat 500 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$8,000
Monitoring:$400
Side Effect Mgmt:$100
Total Annual:$8,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POORICER
$200,000/QALY
QALYs Gained
0.3
Teriparatide Outcomes
for Osteoporosis
Efficacy Outcomes
Overall Effectiveness
+70%
Common Side Effects
Nausea
+9%
Leg cramps
+7%
Dizziness
+9%
Hypercalcemia
+7%
Hypotension
+2%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
14 completed trials for Teriparatide in Osteoporosis
A Comparison of PF708 and Forteo in Osteoporosis Patients
NCT03002428COMPLETEDPHASE3
181 participants
INTERVENTIONAL
Birmingham, United States +25 more
Started: Dec 1, 2016
Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action
NCT01293292COMPLETEDPHASE4
19 participants
INTERVENTIONAL
Sheffield, United Kingdom
Started: Jan 1, 2011
A Comparison Study of PF708 and Forteo in Healthy Subjects
NCT02656810COMPLETEDPHASE1
70 participants
INTERVENTIONAL
Evansville, United States
Started: Dec 1, 2015
Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis
NCT00489918COMPLETEDPHASE2
165 participants
INTERVENTIONAL
Started: Jun 1, 2007
Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis
NCT00259298COMPLETEDPHASE4
12 participants
INTERVENTIONAL
London, United Kingdom
Started: Nov 1, 2005
Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy
NCT00577863COMPLETEDPHASE3
200 participants
INTERVENTIONAL
Huntsville, United States +17 more
Started: Jan 1, 2008
Study of FORTEO Use in Subjects in the Community Setting
NCT01078805COMPLETED
4.17K participants
OBSERVATIONAL
Lakewood, United States
Started: Aug 1, 2003
Teriparatide Treatment in Patients With Inherited Osteoporosis
NCT01360424COMPLETEDPHASE4
6 participants
INTERVENTIONAL
Helsinki, Finland
Started: May 1, 2011
Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis
NCT01535027COMPLETEDPHASE4
125 participants
INTERVENTIONAL
Vienna, Austria
Started: Mar 1, 2006
A Study for the Transdermal Application of Teriparatide
NCT01011556COMPLETEDPHASE2
233 participants
INTERVENTIONAL
Buenos Aires, Argentina +17 more
Started: Nov 1, 2009
Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults
NCT04747392COMPLETEDPHASE1
64 participants
INTERVENTIONAL
Guangzhou, China
Started: Aug 19, 2020
Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis
NCT00535860COMPLETEDPHASE2
104 participants
INTERVENTIONAL
Hradec Králové, Czechia +9 more
Started: Apr 1, 2008
A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide
NCT00557310COMPLETEDPHASE4
35 participants
INTERVENTIONAL
Tucson, United States +5 more
Started: Nov 1, 2007
Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis
NCT00926380COMPLETEDPHASE2
94 participants
INTERVENTIONAL
Boston, United States
Started: Jun 1, 2009
Showing 20 of 132 total trials